Sanofi

Insider Reports History

Entity: Company
Location: 46 Avenue De La Grande Armee, Paris, France
Signature: /s/ Alexandra Roger, Alexandra Roger, Head of Legal Corporate & Finance
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanofi:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Translate Bio, Inc.	10%+ Owner	Common Stock, par value $0.001 per share	75.7M	$2.88B	$38.00	Sep 14, 2021	Direct
MeiraGTx Holdings plc	10%+ Owner	Ordinary Shares ($0.00003881 par value per share)	11.5M	$73.1M	$6.36	Aug 12, 2024	Through its wholly-owned subsidiary, Sanofi Foreign Participations B.V.
Icosavax, Inc.	10%+ Owner	Common Stock (par value, $0.0001)	3.16M	$49.4M	$15.67	Aug 2, 2021	Through its wholly-owned subsidiary, Aventis Inc.
MeiraGTx Holdings plc	10%+ Owner	Ordinary Shares ($0.00003881 par value per share)	698K	$4.44M	$6.36	Aug 12, 2024	Through its wholly-owned subsidiary Kadmon Corporation, LLC
Icosavax, Inc.	10%+ Owner	Series A-1 Preferred Stock (par value, $0.0001)	0			Aug 2, 2021	Through its wholly-owned subsidiary, Aventis Inc
Icosavax, Inc.	10%+ Owner	Series B-1 Preferred Stock (par value, $0.0001)	0			Aug 2, 2021	Through its wholly-owned subsidiary, Aventis Inc

Showing 1 to 6 of 6 entries

Insider Reports Filed by Sanofi

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
MGTX	MeiraGTx Holdings plc	Aug 12, 2024	0	$0	3	Aug 13, 2024	10%+ Owner
TBIO	Translate Bio, Inc.	Sep 14, 2021	2	$2.74B	4	Sep 14, 2021	10%+ Owner
TBIO	Translate Bio, Inc.	Aug 2, 2021	0	$0	3	Aug 12, 2021	Other*
ICVX	Icosavax, Inc.	Aug 2, 2021	4	$1M	4	Aug 2, 2021	10%+ Owner
ICVX	Icosavax, Inc.	Jul 28, 2021	0	$0	3	Jul 28, 2021	10%+ Owner